In BLCA, COMMD2 activated tumor‐related pathways, such as PI3K/AKT/mTOR, cellular response to hypoxia, DNA repair, tumor proliferation signature, G2M checkpoint, and MYC targets (Figure 10C‐H). Here, COMMD2 is linked to neoplasm.